Literature DB >> 15037339

Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

S Kristian Hill1, Daniel Schuepbach, Ellen S Herbener, Matcheri S Keshavan, John A Sweeney.   

Abstract

The early course of neuropsychological dysfunction in schizophrenia and the impact of treatment on these deficits need to be better specified. A sample of 45 patients with schizophrenia underwent five neuropsychological evaluations from prior to treatment with antipsychotic treatment through a 2-year follow-up period. A comparison sample of 33 matched healthy individuals underwent neuropsychological evaluations at similar time points. At baseline, a generalized deficit across cognitive domains was evident for the schizophrenia sample. After 6 weeks of treatment, patients showed modest improvements in visual memory and visual perception, but a decline in verbal memory. Verbal memory performance returned to baseline levels by the 6-month follow-up while deficits in other neuropsychological domains persisted throughout the 2-year period. Relatively static and generalized neuropsychological dysfunction, evident from illness onset, is consistent with neurodevelopmental rather than neurodegenerative models of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037339     DOI: 10.1016/S0920-9964(03)00213-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  59 in total

1.  Cortical thickness in neuropsychologically near-normal schizophrenia.

Authors:  Derin J Cobia; John G Csernansky; Lei Wang
Journal:  Schizophr Res       Date:  2011-10-07       Impact factor: 4.939

2.  Longitudinal progression of frontal and temporal lobe changes in schizophrenia.

Authors:  Derin J Cobia; Matthew J Smith; Lei Wang; John G Csernansky
Journal:  Schizophr Res       Date:  2012-05-29       Impact factor: 4.939

Review 3.  The development of psychotic disorders in adolescence: a potential role for hormones.

Authors:  Hanan D Trotman; Carrie W Holtzman; Arthur T Ryan; Daniel I Shapiro; Allison N MacDonald; Sandra M Goulding; Joy L Brasfield; Elaine F Walker
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

4.  Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.

Authors:  Beng-Choon Ho; Thomas H Wassink; Steven Ziebell; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

5.  A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis.

Authors:  Dwight Dickinson; J Daniel Ragland; Monica E Calkins; James M Gold; Ruben C Gur
Journal:  Schizophr Res       Date:  2006-04-17       Impact factor: 4.939

6.  Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study.

Authors:  Margot Albus; Werner Hubmann; Fritz Mohr; Susanne Hecht; Petra Hinterberger-Weber; Nichi-Niels Seitz; Helmut Küchenhoff
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-10-09       Impact factor: 5.270

7.  Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.

Authors:  Dwight Dickinson; James M Gold
Journal:  Schizophr Bull       Date:  2007-08-16       Impact factor: 9.306

8.  Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum.

Authors:  Amanda L Rodrigue; Jennifer E McDowell; Neeraj Tandon; Matcheri S Keshavan; Carol A Tamminga; Godfrey D Pearlson; John A Sweeney; Robert D Gibbons; Brett A Clementz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-03-31

Review 9.  Psychoradiology: The Frontier of Neuroimaging in Psychiatry.

Authors:  Su Lui; Xiaohong Joe Zhou; John A Sweeney; Qiyong Gong
Journal:  Radiology       Date:  2016-11       Impact factor: 11.105

10.  Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Authors:  S Kristian Hill; John A Sweeney; Robert M Hamer; Richard S E Keefe; Diana O Perkins; Hongbin Gu; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.